Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News Luke Timmerman 11/12/09 Seattle
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money Luke Timmerman 11/11/09 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News Luke Timmerman 10/15/09 Seattle
Seattle Genetics Adds Marketing Boss Luke Timmerman 10/13/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 Luke Timmerman 09/22/09 Seattle
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs Luke Timmerman 09/18/09 San Diego
Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug Luke Timmerman 09/10/09 San Diego
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News Luke Timmerman 09/10/09 Seattle
Seattle Genetics Gets Milestone Luke Timmerman 09/08/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies Luke Timmerman 08/25/09 Seattle
Seattle Genetics Trial Fills Up Luke Timmerman 08/24/09 Seattle
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News Luke Timmerman 08/20/09 Seattle
iLike Courts MySpace, Microsoft and Nokia Tie the Knot, Madrona Funds Three Startups, & More Seattle-Area Deals News Gregory T. Huang 08/19/09 Seattle
Seattle Genetics Gets $136M Total Luke Timmerman 08/13/09 Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News Luke Timmerman 08/13/09 Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed Luke Timmerman 08/12/09 Seattle
Seattle Genetics Raising $118M Eric Hal Schwartz 08/11/09 Seattle
Seattle Genetics Snags Milestone Luke Timmerman 08/10/09 Seattle
Seattle Genetics Starts New Trial Luke Timmerman 06/18/09 Seattle
NanoString Nabs $30M in Third Venture Round (Which It Hopes Will Be The Last) Luke Timmerman 06/09/09 Seattle
Alder Expands Partnership with Schering-Plough, Adds “Significant” Upfront Cash Luke Timmerman 06/08/09 Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News Luke Timmerman 06/04/09 Seattle
Facebook Funds Seattle Startups, 1000 Markets Gets Seed Financing, Modumetal Closes Equity Round, & More Seattle-Area Deals News Gregory T. Huang 06/02/09 Seattle
Seattle Genetics Pockets $11.5M Luke Timmerman 06/01/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results Luke Timmerman 06/01/09 Seattle
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study Luke Timmerman 06/01/09 Seattle
Vulcan’s Biotech Windfall, BiPar Sciences, Sparks “Fundamental” Cancer Advance Luke Timmerman 05/22/09 Seattle
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results Luke Timmerman 05/15/09 Seattle
Why Should the Public Care About Biotech? Why is the Answer Always Jobs? Luke Timmerman 04/24/09 Seattle
Page 1 of 3 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.